Medindia

X

Reportlinker Adds Biopharmaceuticals - A Global Market Overview

Friday, April 2, 2010 Research News J E 4
Advertisement


NEW YORK, April 1 Reportlinker.com announces that a new market research report is available in its catalogue:

Biopharmaceuticals - A Global Market Overview

http://www.reportlinker.com/p0185959/Biopharmaceuticals---A-Global-Market-Overview.html

`Intense research efforts made biopharmaceuticals the most successful products in various therapeutic areas such as Neurology, Infectious Diseases, Cardiovascular, Oncology etc. Undoubtedly, all the major pharmaceuticals are, now, engaged in doing research for new biopharmaceutical active ingredients. Biopharma active ingredients are containing in about 50% of the newly approved drugs. The future of biopharmaceuticals is to be projected bright as the market share is growing gradually. In terms of market revenue, out of total pharma market the biopharmaceutical products were accounted for about 10% in 2006 and are projected to account for about 15% by 2015.

Biopharmaceutical products analyzed in this study comprise Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, Granulocyte-Colony Stimulating Factor, Recombinant Human Insulin, Interferons, Human Growth Hormones and Other. The report also analyzes the market for biopharmaceutical therapeutic areas including Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other.

The global market for biopharmaceuticals is projected to reach US$182.5 billion by 2015, registering a CAGR of 12.4% during the period 2006-2015. The study includes 131 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global market value in USD by geographic regions and the product segments.

The report analyses the biopharmaceuticals market for global and the regional markets including North America, Western Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 10 independent countries across North America - the United States and Canada; Europe - Germany, The United Kingdom, France, Italy and Spain; Asia-Pacific - Japan, China and India.

This study profiles 53 key global players and 87 major players across North America - 37; Western Europe - 18; Asia-Pacific - 30; and Rest of World - 2. The report also provides the listing of the companies engaged in research, technology development, manufacturing and the supply of biopharmaceuticals. The global list of companies covers addresses, contact numbers and the website addresses of 382 companies.

1. GLOBAL MARKET PERSPECTIVE

1.1 Introduction

1.2 Product Segmentation

1.2.1 Monoclonal Antibodies

1.2.2 Biotechnology Vaccines

1.2.3 Erythropoietin

1.2.3.1 Therapeutic Application

1.2.4 Granulocyte-Colony Stimulating Factor

1.2.4.1 Therapeutic Application

1.2.5 Recombinant Human Insulin

1.2.6 Interferons

1.2.7 Human Growth Hormones

1.2.7.1 Therapeutic Application

Anti-Aging Agent

Athletic Advantages

Side Effects

1.3 Application Analysis

1.3.1 End use Markets for Biopharmaceutical Products

1.3.2 Top-25 Biopharmaceutical Blog Buster Drugs

1.4 Market Trends

1.4.1 Big Pharma Companies to Adopt Virtual Pharma Model for Faster Lead Time

1.4.2 Biopharmaceutical Research Network for Producing Monoclonal Antibodies

1.4.3 European Biopharmaceutical Enterprises to Establish European Biopharmaceutical Innovation Fund

1.4.4 Government Policy to Boost Biopharmaceuticals market in China

1.4.5 Future Looks Bright for Indian Biopharmaceuticals Market

1.5 Key Global Players

Abbott Laboratories

Alexion Pharma

Ambrilia Biopharma Inc.

Amgen

Analytical Biological Services Inc.

AstraZeneca

Atlanta Biologicals, Inc.

Aventis Pharma Limited

AVI BioPharma

Baxter Bioscience Corporation

Bayer AG

BD Biosciences

Beijing Tiantan Biological Products Co., Ltd.

Biocon Ltd.

Biogen Idec

Bio-Rad Laboratories, Inc.

Boehringer Ingelheim

Bristol-Myers Squibb Belgium NV

Bukwang Pharma

CellResearchCorp

Cipla Ltd

Daiichi Sankyo Ltd.

DNA Gateway International, Inc.

Dr. Reddy's Laboratories

Eli Lilly

Genentech

Genzyme

GlaxoSmithKline Pharmaceuticals Limited

Glenmark Pharmaceuticals Ltd.

GVK BIO

Helix BioPharma Corp.

Hualan Biological Engineering Inc.

Johnson & Johnson

LG Life Sciences

Merck Serono S.A

Millipore Corporation

Novartis

Novo Nordisk

OSI Pharmaceuticals, Inc.

Pfizer Inc.

Procter & Gamble Pharmaceuticals

Ranbaxy Laboratories Limited

Reliance Life Sciences

Roche

Sandoz Biogenerics

Sanofi-Aventis

Schering Ag

Shantha Biotechniques Ltd.

Sigma-Aldrich Corporation

Solvay Pharma & Cie

Takeda

Teva Pharmaceutical Industries

UCB S.A.

1.6 Key Business Trends

Pharmaxis Takeover Topigen pharma

Astrazeneca Settles Patent Agreement with Teva Pharmaceuticals

Molecular Insight Pharmaceuticals reduces personnel to synchronize operations

Keryx concludes SPA agreement for Phase III clinical trial for Zerenex

Merz to Bag BioForm Medical

Anika acquires Fidia Advanced Biopolymers

Teva-KOWA to acquire stake in Taisho Pharmaceutical

Novartis Acquires Corthera Inc

AstraZeneca acquires Novexel

Array BioPharma Partners with Amgen for Type 2 Diabetes

BD acquires HandyLab

D-Pharm collaborates with Wanbang Biopharmaceuticals

GPC Biotech AG merges with Agennix AG

China Biopharmaceuticals merges with NeoStem

Bio-Rad signs partnership with Biotest AG for diagnostics

Sanofi-Aventis Acquires France based FOVEA

Sandoz Closes acquisition of EBEWE Pharma

Sanofi-Aventis Acquires Merck's Interest in Merial

Johnson & Johnson acquires Cougar Biotechnology

Baxter signs agreement with Edwards Life sciences for CRRT

MannKind acquires insulin assets from Pfizer

Alder expands collaboration with Schering-Plough

Akela Pharma Merges with Nventa Biopharmaceuticals

Takeda acquires IDM Pharma

GVK Biosciences Signs Clinical Research Partnership with Excel Pharma

Acquisition of Medley strengthens Sanofi-Aventis position in Brazil

Kendrick acquisition reinforces Sanofi's emerging market maneuver

Roche acquires Genentech

Johnson & Johnson takes over Mentor Corporation

Johnson & Johnson acquires Omrix Biopharmaceuticals Inc.

Teva acquires Barr

GlaxoSmithKline acquires BMS Pakistan

Roche signs agreement to takeover Memory Pharmaceuticals

Lilly acquires ImClone Systems

Acquisition of Alvedon boosts GSK's analgesic portfolio

GSK acquires Genelabs Technologies

Novartis Takeover Nektar

GSK purchase of Laclede's Biotene

Sanofi Pasteur Acquires Acambis

Lilly takes over SGX

Bayer acquires preclinical anti-cancer program from Nycomed

Thermo Fisher takes over FIBERLite Centrifuge

Teva Bags Bentley Pharmaceuticals

Thermo Fisher Acquires Affinity BioReagents

Intas Biopharma Bags Biologisc Process Development

Boehringer Ingelheim acquires Actimis Pharmaceuticals

Itero Biopharma collaborates with Biological E. Ltd.

GVK Bio signs Pact with Wyeth Pharmaceuticals for drug discovery

Takeda acquires Millennium

BD Acquires Cytopeia

DOR BioPharma Signs Development license agreement with Harvard

Abbott Forms Joint Venture with Takeda

Takeda acquires Paradigm Therapeutics

Thermo Fisher acquires Finnzymes

Dr. Reddy's completes two acquisitions

EUSA Pharma Acquires Cytogen

Roche acquires Piramed

Dr. Reddy's Bags Italian Jet Generici Srl.

AVI BioPharma acquires Ercole Biotech

Teva acquires CoGenesys

Roche bullish on biopharmaceuticals

GlaxoSmithKline acquires Reliant Pharmaceuticals

Amgen acquires Ilypsa

Amgen takes over Alantos

1.7 Key Product Trends

FDA Approves Quick Review for Keryx treatment

Cipla Introduces generic drug to treat H1N1

Glenmark Generics (Europe) launches its first four products for the UK market

Keryx Gains orphan drug status for KRX-040

Promius Pharma releases Promiseb(TM)

Amgen to partner GlaxoSmithKline to commercialize denosumab in Europe

Bayer gains entitlement to Bioton's insulin SciLinŪ

Bio-Rad announces Bio-Plex Pro

Glenmark Unveils Azathioprine in the US.

Promius Introduces EPICERAMŪ

Biocon and Abraxis Bioscience Itroduces Abraxane in India

Glenmark Generics launches Tablet for Hypertension

BD Biosciences launches high-performance calcium dye assay kit

1.8 Global Market Overview

1.8.1 Market Overview by Biopharmaceutical Product Segment

1.8.2 Biopharmaceutical Product Market Overview by Global Region

1.8.2.1 Monoclonal Antibodies

1.8.2.2 Biotech Vaccines

1.8.2.3 Erythropoietin

1.8.2.4 Granulocyte-Colony Stimulating Factor

1.8.2.5 Recombinant Human Insulin

1.8.2.6 Interferons

1.8.2.7 Human Growth Hormones

1.8.2.8 Other Biopharmaceuticals

1.8.3 Biopharmaceutical Therapeutic Market Overview by Global Region

1.8.3.1 Oncology

1.8.3.2 Neurology

1.8.3.3 Diabetes

1.8.3.4 Infectious Diseases

1.8.3.5 Cardiovascular

1.8.3.6 Other Disease Areas

2. REGIONAL MARKET PERSPECTIVE

2.1 Regional Market Overview

2.1.1 North America

2.1.1.2 Market Overview by North American Region

2.1.1.3 Market Overview by Biopharmaceutical Product

2.1.1.4 Market Overview by Biopharmaceutical Therapeutic Area

2.1.1.5 Biopharmaceutical Product Market Overview by North American Region

Monoclonal Antibodies

Biotech Vaccines

Erythropoietin

Granulocyte-Colony Stimulating Factor

Recombinant Human Insulin

Interferons

Human Growth Hormones

Other Biopharmaceuticals

2.1.1.6 Major Market Players

Abbott Laboratories (USA)

Accentia Biopharmaceuticals, Inc. (USA)

Advanced Life Sciences, Inc. (USA)

Alder Biopharmaceuticals, Inc. (USA)

Alexion Pharma (USA)

Ambrilia Biopharma Inc. (USA)

Amgen (USA)

Analytical Biological Services Inc. (USA)

Array BioPharma (USA)

Astellas Pharma (USA)

Atlanta Biologicals, Inc. (USA)

AVI BioPharma (USA)

Baxter Bioscience Corporation (USA)

BD Biosciences (USA)

Biodel Inc. (USA)

Biogen Idec (USA)

Bio-Rad Laboratories, Inc. (USA)

DNA Gateway International, Inc. (USA)

Eli Lilly (USA)

EUSA Pharma (USA)

Genentech (USA)

Genzyme (USA)

Helix BioPharma Corp. (USA)

Hemispherx Biopharma, Inc. (USA)

IBI International LLC (USA)

Johnson & Johnson's (USA)

Millipore Corporation (USA)

Neurobiological Technologies, Inc. (USA)

Novozymes Biopharma (USA)

OSI Pharmaceuticals, Inc. (USA)

Pfizer Inc. (USA)

Procter & Gamble Pharmaceuticals (USA)

Provenance BioPharmaceuticals (USA)

Sigma-Aldrich Corporation (USA)

Soligenix, Inc. (USA)

ZymoGenetics (USA)

Pacgen Biopharmaceuticals Corporation (Canada)

2.1.1.7 North American Market Overview by Country

The United States

Canada

2.1.2 Western Europe

2.1.2.1 Market Overview by Western Europe Region

2.1.2.3 Market Overview by Biopharmaceutical Product

2.1.2.3 Market Overview by Biopharmaceutical Therapeutic Area

2.1.2.4 Biopharmaceutical Product Market Overview by Western Europe Region

Monoclonal Antibodies

Biotech Vaccines

Erythropoietin

Granulocyte-Colony Stimulating Factor

Recombinant Human Insulin

Interferons

Human Growth Hormones

Other Biopharmaceuticals

2.1.2.5 Major Market Players

Agennix AG (Germany)

AstraZeneca (United Kingdom)

Bayer AG (Germany)

Boehringer Ingelheim (Germany)

Bristol-Myers Squibb Belgium NV (Belgium)

CellGenix Technologie Transfer GmbH (Germany)

GlaxoSmithKline Pharmaceuticals Limited (United Kingdom)

Merck Serono S.A (Switzerland)

Novartis (Switzerland)

Novo Nordisk (Denmark)

PromoCell GmbH (Germany)

Pronova BioPharma (Norway)

Roche (Switzerland)

Sandoz Biogenerics (Germany)

Sanofi-Aventis (France)

Schering Ag (Germany)

Solvay Pharma & Cie (Belgium)

UCB S.A. (Belgium)

2.1.2.6 Western Europe Market Overview by Country

Germany

The United Kingdom

France

Italy

Spain

Rest of Western Europe

2.1.3 Asia-Pacific

2.1.3.1 Market Overview by Asia-Pacific Region

2.1.3.2 Market Overview by Biopharmaceutical Product

2.1.3.3 Market Overview by Biopharmaceutical Therapeutic Area

2.1.3.4 Biopharmaceutical Product Market Overview by Asia-Pacific Region

Monoclonal Antibodies

Biotech Vaccines

Erythropoietin

Granulocyte-Colony Stimulating Factor

Recombinant Human Insulin

Interferons

Human Growth Hormones

Other Biopharmaceuticals

2.1.3.5 Major Market Players

Aurobindo Pharma Ltd. (India)

Aventis Pharma Limited (India)

Beijing SL Pharmaceutical Co., Ltd. (China)

Beijing Tiantan Biological Products Co., Ltd. (China)

Biocon Ltd. (India)

Biological E Limited (India)

Bukwang Pharma (South Korea)

CellResearchCorp (Singapore)

Cipla Ltd (India)

Da An Gene Co., Ltd (China)

Daiichi Sankyo Ltd. (Japan)

Dr. Reddy's Laboratories (India)

Glenmark Pharmaceuticals Ltd. (India)

GVK BIO (India)

Hualan Biological Engineering Inc. (China)

i-DNA Biotechnology (Singapore)

LG Life Sciences (South Korea)

Panacea Biotech Ltd. (India)

Ranbaxy Laboratories Limited (India)

Reliance Life Sciences (India)

RPG Life Sciences Ltd. (India)

SciGen (Singapore)

Shanghai Institute of Biological Products (China)

Shantha Biotechniques Ltd. (India)

Shenzhen Neptunus Bioengineering Co., Ltd. (China)

Sun Pharmaceutical Industries Ltd. (India)

Suven Life Sciences Ltd. (India)

Takeda (Japan)

Torrent Pharmaceuticals Ltd. (India)

Zydus Cadila Ltd. (India)

2.1.3.6 Asia-Pacific Market Overview by Country

Japan

China

India

Rest of Asia-Pacific

2.1.4 Rest of World

2.1.4.1 Market Overview by Biopharmaceutical Product

2.1.4.2 Market Overview by Biopharmaceutical Therapeutic Area

2.1.4.3 Major Market Players

D-Pharm Ltd. (Israel)

Teva Pharmaceutical Industries (Israel)

3. GUIDE TO THE INDUSTRY

3.1 North America

3.1.1 United States

3.1.2 Canada

3.2 Europe

3.2.1 Germany

3.2.2 United Kingdom

3.2.3 France

3.2.4 Belgium

3.2.5 Denmark

3.2.6 Ireland

3.2.7 Norway

3.2.8 Sweden

3.2.9 Switzerland

3.2.10 The Netherlands

3.3 Asia-Pacific

3.3.1 Japan

3.3.2 China

3.3.3 India

3.3.4 Australia

3.3.5 Hong Kong

3.3.6 Indonesia

3.3.7 Malaysia

3.3.8 Singapore

3.3.9 South Korea

3.3.10 Taiwan

3.4 Rest of World

3.4.1 Brazil

3.4.2 Israel

4. ANNEXURE

4.1 Research Methodology

4.2 The Questionnaire

4.3 Feedback

Charts & Graphs

GLOBAL MARKET PERSPECTIVE

Chart 1: Global Biopharmaceuticals Market Analysis (2006-2015) by Therapeutic Area - Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other in USD Million

Chart 2: Glance at 2006, 2010 and 2015 Global Biopharmaceuticals Market Share (%) by Therapeutic Area - Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other

Chart 3: Global Sales of Blog Buster Drugs (2008 & 2009) in USD Million

Chart 4: Global Biopharmaceuticals Market Analysis (2006-2015) in USD Million

Chart 5: Global Biopharmaceuticals Market Analysis (2006-2015) by Product Segment Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million

Chart 6: Glance at 2006, 2010 and 2015 Global Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other

Chart 7: Global Monoclonal Antibodies Market Analysis (2006-2015) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million

Chart 8: Glance at 2006, 2010 and 2015 Global Monoclonal Antibodies Market Share (%) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World

Chart 9: Global Biotech Vaccines Market Analysis (2006-2015) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million

Chart 10: Glance at 2006, 2010 and 2015 Global Biotech Vaccines Market Share (%) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World

Chart 11: Global Erythropoietin Market Analysis (2006-2015) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million

Chart 12: Glance at 2006, 2010 and 2015 Global Erythropoietin Market Share (%) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World

Chart 13: Global G-CSF Market Analysis (2006-2015) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million

Chart 14: Glance at 2006, 2010 and 2015 Global G-CSF Market Share (%) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World

Chart 15: Global Monoclonal Antibodies Market Analysis (2006-2015) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million

Chart 16: Glance at 2006, 2010 and 2015 Global Monoclonal Antibodies Market Share (%) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World

Chart 17: Global Interferons Market Analysis (2006-2015) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million

Chart 18: Glance at 2006, 2010 and 2015 Global Interferons Market Share (%) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World

Chart 19: Global HG Hormones Market Analysis (2006-2015) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million

Chart 20: Glance at 2006, 2010 and 2015 Global HG Hormones Market Share (%) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World

Chart 21: Global Other Biopharmaceuticals Market Analysis (2006-2015) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million

Chart 22: Glance at 2006, 2010 and 2015 Global Other Biopharmaceuticals Market Share (%) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World

Chart 23: Global Biopharmaceuticals Market Analysis (2006-2015) in Oncology by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million

Chart 24: Glance at 2006, 2010 and 2015 Global Oncology Market Share (%) of Biopharmaceuticals by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World

Chart 25: Global Biopharmaceuticals Market Analysis (2006-2015) in Neurology by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million

Chart 26: Glance at 2006, 2010 and 2015 Global Neurology Market Share (%) of Biopharmaceuticals by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World

Chart 27: Global Biopharmaceuticals Market Analysis (2006-2015) in Diabetes by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million

Chart 28: Glance at 2006, 2010 and 2015 Global Diabetes Market Share (%) of Biopharmaceuticals by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World

Chart 29: Global Biopharmaceuticals Market Analysis (2006-2015) in Infectious Diseases by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million

Chart 30: Glance at 2006, 2010 and 2015 Global Infectious Diseases Market Share (%) of Biopharmaceuticals by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World

Chart 31: Global Biopharmaceuticals Market Analysis (2006-2015) in Cardiovascular by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million

Chart 32: Glance at 2006, 2010 and 2015 Global Cardiovascular Market Share (%) of Biopharmaceuticals by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World

Chart 33: Global Biopharmaceuticals Market Analysis (2006-2015) in Other Disease Areas by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million

Chart 34: Glance at 2006, 2010 and 2015 Global Other Disease Areas Market Share (%) of Biopharmaceuticals by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World

REGIONAL MARKET PERSPECTIVE

Chart 35: The Projection of Largest Regions in terms of Market Growth for Biopharmaceuticals by Geography - Asia-Pacific, Europe and North America

Chart 36: Global Biopharmaceuticals Market Analysis (2006-2015) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million

Chart 37: Glance at 2006, 2010 and 2015 Global Biopharmaceuticals Market Share (%) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World

NORTHE AMERICA

Chart 38: North American Biopharmaceuticals Market Analysis (2006-2015) by Geographic Region - United States and Canada in USD Million

Chart 39: Glance at 2006, 2010 and 2015 North American Biopharmaceuticals Market Share (%) by Geographic Region - United States and Canada

Chart 40: North American Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million

Chart 41: Glance at 2006, 2010 and 2015 North American Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin,Interferons, HG Hormones and Other

Chart 42: North American Biopharmaceuticals Market Analysis (2006-2015) by Therapeutic Area - Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other in USD Million

Chart 43: Glance at 2006, 2010 and 2015 North American Biopharmaceuticals Market Share (%) by Therapeutic Area - Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other

Chart 44: North American Monoclonal Antibodies Market (2006-2015) by Geographic Region - United States and Canada in USD Million

Chart 45: Glance at 2006, 2010 and 2015 North American Monoclonal Antibodies Market Share (%) by Geographic Region - United States and Canada

Chart 46: North American Biotech Vaccines Market Analysis (2006-2015) by Geographic Region - United States and Canada in USD Million

Chart 47: Glance at 2006, 2010 and 2015 North American Biotech Vaccines Market Share (%) by Geographic Region - United States and Canada

Chart 48: North American Erythropoietin Market Analysis (2006-2015) by Geographic Region - United States and Canada in USD Million

Chart 49: Glance at 2006, 2010 and 2015 North American Erythropoietin Market Share (%) by Geographic Region - United States and Canada

Chart 50: North American G-CSF Market Analysis (2006-2015) by Geographic Region - United States and Canada in USD Million

Chart 51: Glance at 2006, 2010 and 2015 North American G-CSF Market Share (%) by Geographic Region - United States and Canada

Chart 52: North American RH Insulin Market Analysis (2006-2015) by Geographic Region - United States and Canada in USD Million

Chart 53: Glance at 2006, 2010 and 2015 North American RH Insulin Market Share (%) by Geographic Region - United States and Canada

Chart 54: North American Interferons Market Analysis (2006-2015) by Geographic Region - United States and Canada in USD Million

Chart 55: Glance at 2006, 2010 and 2015 North American Interferons Market Share (%) by Geographic Region - United States and Canada

Chart 56: North American HG Hormones Market Analysis (2006-2015) by Geographic Region - United States and Canada in USD Million

Chart 57: Glance at 2006, 2010 and 2015 North American HG Hormones Market Share (%) by Geographic Region - United States and Canada

Chart 58: North American Other Biopharmaceuticals Market Analysis (2006-2015) by Geographic Region - United States and Canada in USD Million

Chart 59: Glance at 2006, 2010 and 2015 North American Other Biopharmaceuticals Market Share (%) by Geographic Region -United States and Canada

The United States

Chart 60: United States Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million

Chart 61: Glance at 2006, 2010 and 2015 United States Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other

Canada

Chart 62: Canadian Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million

Chart 63: Glance at 2006, 2010 and 2015 Canadian Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other

WESTERN EUROPE

Chart 64: Western Europe Biopharmaceuticals Market Analysis (2006-2015) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million

Chart 65: Glance at 2006, 2010 and 2015 Western Europe Biopharmaceuticals Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE

Chart 66: Western Europe Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million

Chart 67: Glance at 2006, 2010 and 2015 Western Europe Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other

Chart 68: Western Europe Biopharmaceuticals Market Analysis (2006-2015) by Therapeutic Area - Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other in USD Million

Chart 69: Glance at 2006, 2010 and 2015 Western Europe Biopharmaceuticals Market Share (%) by Therapeutic Area - Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other

Chart 70: Western Europe Monoclonal Antibodies Market Analysis (2006-2015) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million

Chart 71: Glance at 2006, 2010 and 2015 Western Europe Monoclonal Antibodies Market Share (%) by Geographic Region -Germany, United Kingdom, France, Italy, Spain and Rest of WE

Chart 72: Western Europe Biotech Vaccines Market Analysis (2006-2015) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million

Chart 73: Glance at 2006, 2010 and 2015 Western Europe Biotech Vaccines Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE

Chart 74: Western Europe Erythropoietin Market Analysis (2006-2015) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million

Chart 75: Glance at 2006, 2010 and 2015 Western Europe Erythropoietin Market Share (%) by Geographic Region -Germany, United Kingdom France, Italy, Spain and Rest of WE

Chart 76: Western Europe G-CSF Market Analysis (2006-2015) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million

Chart 77: Glance at 2006, 2010 and 2015 Western Europe G-CSF Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE

Chart 78: Western Europe RH Insulin Market Analysis (2006-2015) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million

Chart 79: Glance at 2006, 2010 and 2015 Western Europe RH Insulin Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE

Chart 80: Western Europe Interferons Market Analysis (2006-2015) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million

Chart 81: Glance at 2006, 2010 and 2015 Western Europe Interferons Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE

Chart 82: Western Europe HG Hormones Market Analysis (2006-2015) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million

Chart 83: Glance at 2006, 2010 and 2015 Western Europe HG Hormones Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE

Chart 84: Western Europe Other Biopharmaceuticals Market Analysis (2006-2015) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million

Chart 85: Glance at 2006, 2010 and 2015 Western Europe Other Biopharmaceuticals Market Share (%) by Geographic Region -Germany, United Kingdom, France, Italy, Spain and Rest of WE

Germany

Chart 86: German Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million

Chart 87: Glance at 2006, 2010 and 2015 German Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other

The United Kingdom

Chart 88: United Kingdom Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million

Chart 89: Glance at 2006, 2010 and 2015 United Kingdom Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other

France

Chart 90: French Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million

Chart 91: Glance at 2006, 2010 and 2015 French Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other

Italy

Chart 92: Italian Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million

Chart 93: Glance at 2006, 2010 and 2015 Italian Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other

Spain

Chart 94: Spanish Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million

Chart 95: Glance at 2006, 2010 and 2015 Spanish Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other

Rest of Western Europe

Chart 96: Rest of WE Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million

Chart 97: Glance at 2006, 2010 and 2015 Rest of WE Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other

ASIA-PACIFIC

Chart 98: Asia-Pacific Biopharmaceuticals Market Analysis (2006-2015) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million

Chart 99: Glance at 2006, 2010 and 2015 Asia-Pacific Biopharmaceuticals Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific

Chart 100: Asia-Pacific Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million

Chart 101: Glance at 2006, 2010 and 2015 Asia-Pacific Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other

Chart 102: Asia-Pacific Biopharmaceuticals Market Analysis (2006-2015) by Therapeutic Area - Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other in USD Million

Chart 103: Glance at 2006, 2010 and 2015 Asia-Pacific Biopharmaceuticals Market Share (%) by Therapeutic Area - Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other

Chart 104: Asia-Pacific Monoclonal Antibodies Market Analysis (2006-2015) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million

Chart 105: Glance at 2006, 2010 and 2015 Asia-Pacific Monoclonal Antibodies Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific

Chart 106: Asia-Pacific Biotech Vaccines Market Analysis (2006-2015) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million

Chart 107: Glance at 2006, 2010 and 2015 Asia-Pacific Biotech Vaccines Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific

Chart 108: Asia-Pacific Erythropoietin Market Analysis (2006-2015) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million

Chart 109: Glance at 2006, 2010 and 2015 Asia-Pacific Erythropoietin Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific

Chart 110: Asia-Pacific G-CSF Market Analysis (2006-2015) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million

Chart 111: Glance at 2006, 2010 and 2015 Asia-Pacific G-CSF Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific

Chart 112: Asia-Pacific RH Insulin Market Analysis (2006-2015) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million

Chart 113: Glance at 2006, 2010 and 2015 Asia-Pacific RH Insulin Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific

Chart 114: Asia-Pacific Interferons Market Analysis (2006-2015) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million

Chart 115: Glance at 2006, 2010 and 2015 Asia-Pacific Interferons Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific

Chart 116: Asia-Pacific HG Hormones Market Analysis (2006-2015) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million

C

To order this report:

Biotechnology Industry: Biopharmaceuticals - A Global Market Overview

More Market Research Report

Check our Company Profile, SWOT and Revenue Analysis!

Contact Nicolas Bombourg Reportlinker Email: nbo@reportlinker.com US: (805)652-2626 Intl: +1 805-652-2626

SOURCE Reportlinker
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Reportlinker Adds Innovations in Healthier Alcohol...
S
Reportlinker Adds The Specialty Pharmaceutical Mar...